Skip to main content

Pfizer wants to expand human trials of coronavirus vaccine to thousands of people by September

The U.S.-based pharmaceutical giant, which is working alongside German drugmaker BioNTech, last week dosed its first participants in the United States with a potential Covid-19 vaccine.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.